Exercise or conversion by Throne Jason of 4485 shares of Ideaya Biosciences subject to Rule 16b-3

IDYA Stock  USD 25.86  0.56  2.21%   
About 57% of all Ideaya Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that some traders are interested. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Ideaya Biosciences Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Ideaya insider trading alert for exercise of common stock by Throne Jason, Chief Legal Officer, on 12th of July 2023. This event was filed by Ideaya Biosciences Inc with SEC on 2023-07-12. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Ideaya Biosciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Ideaya Biosciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Ideaya Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Ideaya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ideaya Biosciences Fundamental Analysis

We analyze Ideaya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Ideaya Biosciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Ideaya Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ideaya Biosciences stock to make a market-neutral strategy. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with similar companies.

Peers

Ideaya Biosciences Related Equities

XFORX4 Pharmaceuticals   39.66   
0%
100.0%
ABOSAcumen Pharmaceuticals   6.15   
0%
15.0%
INZYInozyme Pharma   3.75   
0%
9.0%
VRNAVerona Pharma   3.73   
0%
9.0%
MLTXMoonLake Immunotherapeuti   3.28   
0%
8.0%
VTYXVentyx Biosciences   2.64   
0%
6.0%
RVMDRevolution Medicines   2.03   
0%
5.0%
DAWNDay One   1.82   
0%
4.0%
AMLXAmylyx Pharmaceuticals   1.75   
0%
4.0%
TERNTerns Pharmaceuticals   1.21   
0%
3.0%
SWTXSpringWorks Therapeutics   0.90   
0%
2.0%
KROSKeros Therapeutics   0.60   
0%
1.0%
PTGXProtagonist Therapeutics   0.53   
0%
1.0%
RNAAvidity Biosciences   0.73   
1.0%
0%
MGTXMeiraGTx Holdings   0.97   
2.0%
0%
ANABAnaptysBio   1.08   
2.0%
0%
SNDXSyndax Pharmaceuticals   1.15   
2.0%
0%

Complementary Tools for Ideaya Stock analysis

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios